Loading…
Risperidone Treatment of Bipolar Mania
Objective: To review clinical trial evidence regarding the efficacy and safety of risperidone for the treatment of bipolar mania. Data Sources: Articles were identified through searches of PubMed (1950–August 2005), EMBASE (1988–August 2005 week 37), and International Pharmaceutical Abstracts (1970–...
Saved in:
| Published in: | The Annals of pharmacotherapy 2006-04, Vol.40 (4), p.674-682 |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c374t-280127e00680de7efe5422481219a55b87c4cc1cac65c710614a04dc7de57a5a3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c374t-280127e00680de7efe5422481219a55b87c4cc1cac65c710614a04dc7de57a5a3 |
| container_end_page | 682 |
| container_issue | 4 |
| container_start_page | 674 |
| container_title | The Annals of pharmacotherapy |
| container_volume | 40 |
| creator | Nguyen, Lisa N Guthrie, Sally K |
| description | Objective:
To review clinical trial evidence regarding the efficacy and safety of risperidone for the treatment of bipolar mania.
Data Sources:
Articles were identified through searches of PubMed (1950–August 2005), EMBASE (1988–August 2005 week 37), and International Pharmaceutical Abstracts (1970–August 2005) databases using the key words risperidone, atypical antipsychotics, and bipolar mania. Additional references were found through review of bibliographies of identified articles. PubMed searches for efficacy and safety were limited to clinical trials.
Study Selection and Data Extraction:
Six randomized trials and 6 observational studies of risperidone monotherapy or combination therapy for bipolar mania in adults were selected.
Data Synthesis:
Randomized, placebo-controlled and observational trials reported that risperidone monotherapy decreases manic symptoms in patients with a moderate severity of mania, as determined by change in Young Mania Rating Scale (YMRS) scores. Adverse effects observed in monotherapy trials included somnolence, extrapyramidal symptoms (EPS), and weight gain. Clinical trials of risperidone in combination with other mood stabilizers (ie, lithium, valproate, carbamazepine, topiramate) also reported decreases in YMRS scores in patients with moderate and severe manic symptoms.
Conclusions:
Risperidone monotherapy or adjunctive therapy with other first-line mood stabilizers may be effective for the treatment of acute bipolar mania in adults with moderate severity of mania. The use of risperidone as monotherapy in severe mania or in maintenance treatment remains to be elucidated. |
| doi_str_mv | 10.1345/aph.1G378 |
| format | article |
| fullrecord | <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1345_aph_1G378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1345_aph.1G378</sage_id><sourcerecordid>10.1345_aph.1G378</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-280127e00680de7efe5422481219a55b87c4cc1cac65c710614a04dc7de57a5a3</originalsourceid><addsrcrecordid>eNptj01LAzEURYMoVqsL_4DMxoKLqS-ZZDKz1KJVqAhS1-E1k2lT5oukZfDfG-1AN67eWxzuvYeQGwpTmnDxgN1mSueJzE7IBRWcxSmTcBp-SCEGlsGIXHq_BYCcsvycjGgq0jyj9IJMPq3vjLNF25ho6QzuatPsoraMnmzXVuiid2wsXpGzEitvroc7Jl8vz8vZa7z4mL_NHhexTiTfxaGKMmkA0gwKI01pwhrGM8pojkKsMqm51lSjToWWYR7lCLzQsjBCosBkTO4Pudq13jtTqs7ZGt23oqB-XVVwVX-ugb09sN1-VZviSA5yAbgbAPQaq9Jho60_clJCljAWuMmB87g2atvuXRMc_20cAjd2vemtM8rXWFWhn6q-7zkorlLJkx9sCHOO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Risperidone Treatment of Bipolar Mania</title><source>SAGE</source><creator>Nguyen, Lisa N ; Guthrie, Sally K</creator><creatorcontrib>Nguyen, Lisa N ; Guthrie, Sally K</creatorcontrib><description>Objective:
To review clinical trial evidence regarding the efficacy and safety of risperidone for the treatment of bipolar mania.
Data Sources:
Articles were identified through searches of PubMed (1950–August 2005), EMBASE (1988–August 2005 week 37), and International Pharmaceutical Abstracts (1970–August 2005) databases using the key words risperidone, atypical antipsychotics, and bipolar mania. Additional references were found through review of bibliographies of identified articles. PubMed searches for efficacy and safety were limited to clinical trials.
Study Selection and Data Extraction:
Six randomized trials and 6 observational studies of risperidone monotherapy or combination therapy for bipolar mania in adults were selected.
Data Synthesis:
Randomized, placebo-controlled and observational trials reported that risperidone monotherapy decreases manic symptoms in patients with a moderate severity of mania, as determined by change in Young Mania Rating Scale (YMRS) scores. Adverse effects observed in monotherapy trials included somnolence, extrapyramidal symptoms (EPS), and weight gain. Clinical trials of risperidone in combination with other mood stabilizers (ie, lithium, valproate, carbamazepine, topiramate) also reported decreases in YMRS scores in patients with moderate and severe manic symptoms.
Conclusions:
Risperidone monotherapy or adjunctive therapy with other first-line mood stabilizers may be effective for the treatment of acute bipolar mania in adults with moderate severity of mania. The use of risperidone as monotherapy in severe mania or in maintenance treatment remains to be elucidated.</description><identifier>ISSN: 1060-0280</identifier><identifier>EISSN: 1542-6270</identifier><identifier>DOI: 10.1345/aph.1G378</identifier><identifier>PMID: 16569811</identifier><identifier>CODEN: APHRER</identifier><language>eng</language><publisher>Los Angeles, CA: Harvey Whitney Books</publisher><subject>Antipsychotic Agents - administration & dosage ; Antipsychotic Agents - adverse effects ; Antipsychotic Agents - therapeutic use ; Biological and medical sciences ; Bipolar Disorder - drug therapy ; Bipolar Disorder - psychology ; Clinical Trials as Topic ; Databases, Factual ; Drug Therapy, Combination ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; PubMed ; Risperidone - administration & dosage ; Risperidone - adverse effects ; Risperidone - therapeutic use ; Treatment Outcome</subject><ispartof>The Annals of pharmacotherapy, 2006-04, Vol.40 (4), p.674-682</ispartof><rights>Copyright © 2006 Harvey Whitney Books Company</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-280127e00680de7efe5422481219a55b87c4cc1cac65c710614a04dc7de57a5a3</citedby><cites>FETCH-LOGICAL-c374t-280127e00680de7efe5422481219a55b87c4cc1cac65c710614a04dc7de57a5a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17708322$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16569811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Lisa N</creatorcontrib><creatorcontrib>Guthrie, Sally K</creatorcontrib><title>Risperidone Treatment of Bipolar Mania</title><title>The Annals of pharmacotherapy</title><addtitle>Ann Pharmacother</addtitle><description>Objective:
To review clinical trial evidence regarding the efficacy and safety of risperidone for the treatment of bipolar mania.
Data Sources:
Articles were identified through searches of PubMed (1950–August 2005), EMBASE (1988–August 2005 week 37), and International Pharmaceutical Abstracts (1970–August 2005) databases using the key words risperidone, atypical antipsychotics, and bipolar mania. Additional references were found through review of bibliographies of identified articles. PubMed searches for efficacy and safety were limited to clinical trials.
Study Selection and Data Extraction:
Six randomized trials and 6 observational studies of risperidone monotherapy or combination therapy for bipolar mania in adults were selected.
Data Synthesis:
Randomized, placebo-controlled and observational trials reported that risperidone monotherapy decreases manic symptoms in patients with a moderate severity of mania, as determined by change in Young Mania Rating Scale (YMRS) scores. Adverse effects observed in monotherapy trials included somnolence, extrapyramidal symptoms (EPS), and weight gain. Clinical trials of risperidone in combination with other mood stabilizers (ie, lithium, valproate, carbamazepine, topiramate) also reported decreases in YMRS scores in patients with moderate and severe manic symptoms.
Conclusions:
Risperidone monotherapy or adjunctive therapy with other first-line mood stabilizers may be effective for the treatment of acute bipolar mania in adults with moderate severity of mania. The use of risperidone as monotherapy in severe mania or in maintenance treatment remains to be elucidated.</description><subject>Antipsychotic Agents - administration & dosage</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Bipolar Disorder - drug therapy</subject><subject>Bipolar Disorder - psychology</subject><subject>Clinical Trials as Topic</subject><subject>Databases, Factual</subject><subject>Drug Therapy, Combination</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>PubMed</subject><subject>Risperidone - administration & dosage</subject><subject>Risperidone - adverse effects</subject><subject>Risperidone - therapeutic use</subject><subject>Treatment Outcome</subject><issn>1060-0280</issn><issn>1542-6270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNptj01LAzEURYMoVqsL_4DMxoKLqS-ZZDKz1KJVqAhS1-E1k2lT5oukZfDfG-1AN67eWxzuvYeQGwpTmnDxgN1mSueJzE7IBRWcxSmTcBp-SCEGlsGIXHq_BYCcsvycjGgq0jyj9IJMPq3vjLNF25ho6QzuatPsoraMnmzXVuiid2wsXpGzEitvroc7Jl8vz8vZa7z4mL_NHhexTiTfxaGKMmkA0gwKI01pwhrGM8pojkKsMqm51lSjToWWYR7lCLzQsjBCosBkTO4Pudq13jtTqs7ZGt23oqB-XVVwVX-ugb09sN1-VZviSA5yAbgbAPQaq9Jho60_clJCljAWuMmB87g2atvuXRMc_20cAjd2vemtM8rXWFWhn6q-7zkorlLJkx9sCHOO</recordid><startdate>20060401</startdate><enddate>20060401</enddate><creator>Nguyen, Lisa N</creator><creator>Guthrie, Sally K</creator><general>Harvey Whitney Books</general><general>SAGE Publications</general><general>Whitney</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20060401</creationdate><title>Risperidone Treatment of Bipolar Mania</title><author>Nguyen, Lisa N ; Guthrie, Sally K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-280127e00680de7efe5422481219a55b87c4cc1cac65c710614a04dc7de57a5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Antipsychotic Agents - administration & dosage</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Bipolar Disorder - drug therapy</topic><topic>Bipolar Disorder - psychology</topic><topic>Clinical Trials as Topic</topic><topic>Databases, Factual</topic><topic>Drug Therapy, Combination</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>PubMed</topic><topic>Risperidone - administration & dosage</topic><topic>Risperidone - adverse effects</topic><topic>Risperidone - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Lisa N</creatorcontrib><creatorcontrib>Guthrie, Sally K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The Annals of pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Lisa N</au><au>Guthrie, Sally K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risperidone Treatment of Bipolar Mania</atitle><jtitle>The Annals of pharmacotherapy</jtitle><addtitle>Ann Pharmacother</addtitle><date>2006-04-01</date><risdate>2006</risdate><volume>40</volume><issue>4</issue><spage>674</spage><epage>682</epage><pages>674-682</pages><issn>1060-0280</issn><eissn>1542-6270</eissn><coden>APHRER</coden><abstract>Objective:
To review clinical trial evidence regarding the efficacy and safety of risperidone for the treatment of bipolar mania.
Data Sources:
Articles were identified through searches of PubMed (1950–August 2005), EMBASE (1988–August 2005 week 37), and International Pharmaceutical Abstracts (1970–August 2005) databases using the key words risperidone, atypical antipsychotics, and bipolar mania. Additional references were found through review of bibliographies of identified articles. PubMed searches for efficacy and safety were limited to clinical trials.
Study Selection and Data Extraction:
Six randomized trials and 6 observational studies of risperidone monotherapy or combination therapy for bipolar mania in adults were selected.
Data Synthesis:
Randomized, placebo-controlled and observational trials reported that risperidone monotherapy decreases manic symptoms in patients with a moderate severity of mania, as determined by change in Young Mania Rating Scale (YMRS) scores. Adverse effects observed in monotherapy trials included somnolence, extrapyramidal symptoms (EPS), and weight gain. Clinical trials of risperidone in combination with other mood stabilizers (ie, lithium, valproate, carbamazepine, topiramate) also reported decreases in YMRS scores in patients with moderate and severe manic symptoms.
Conclusions:
Risperidone monotherapy or adjunctive therapy with other first-line mood stabilizers may be effective for the treatment of acute bipolar mania in adults with moderate severity of mania. The use of risperidone as monotherapy in severe mania or in maintenance treatment remains to be elucidated.</abstract><cop>Los Angeles, CA</cop><pub>Harvey Whitney Books</pub><pmid>16569811</pmid><doi>10.1345/aph.1G378</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1060-0280 |
| ispartof | The Annals of pharmacotherapy, 2006-04, Vol.40 (4), p.674-682 |
| issn | 1060-0280 1542-6270 |
| language | eng |
| recordid | cdi_crossref_primary_10_1345_aph_1G378 |
| source | SAGE |
| subjects | Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Biological and medical sciences Bipolar Disorder - drug therapy Bipolar Disorder - psychology Clinical Trials as Topic Databases, Factual Drug Therapy, Combination Humans Medical sciences Pharmacology. Drug treatments PubMed Risperidone - administration & dosage Risperidone - adverse effects Risperidone - therapeutic use Treatment Outcome |
| title | Risperidone Treatment of Bipolar Mania |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T15%3A31%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risperidone%20Treatment%20of%20Bipolar%20Mania&rft.jtitle=The%20Annals%20of%20pharmacotherapy&rft.au=Nguyen,%20Lisa%20N&rft.date=2006-04-01&rft.volume=40&rft.issue=4&rft.spage=674&rft.epage=682&rft.pages=674-682&rft.issn=1060-0280&rft.eissn=1542-6270&rft.coden=APHRER&rft_id=info:doi/10.1345/aph.1G378&rft_dat=%3Csage_cross%3E10.1345_aph.1G378%3C/sage_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c374t-280127e00680de7efe5422481219a55b87c4cc1cac65c710614a04dc7de57a5a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/16569811&rft_sage_id=10.1345_aph.1G378&rfr_iscdi=true |